Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 541 AL 555

Radical Revelations: The Interplay of Nitrosative Stress, the Endocannabinoid System, and Treatment of Age-Related Disorders

Davis A, Casmedes IY, Burton MD.

Int J Mol Sci. 2026 Mar 20;27(6):2813. doi: 10.3390/ijms27062813.

Neuroprotective role of cyanidin in Alzheimer's and Parkinson's disease: current insights and the road ahead

Bashir B, Andotra N, Sharma P, Sharma T, Chauhan S, Awasthi A, Singh S, Singh TG, Singh SK, Vishwas S.

Inflammopharmacology. 2026 May 23. doi: 10.1007/s10787-026-02271-w. Online ahead of print.

Neuroprotective Herbs Associated with Parkinson's and Alzheimer's Disease

Marțiș GS, Ungur RA, Pop A, Bordean EM, Pașca C, Borda IM.

Nutrients. 2026 Jan 29;18(3):439. doi: 10.3390/nu18030439.

The effect of GLP-1 receptor agonists on autophagy: insights gathered from research evaluating neurodegenerative disorders with these agents

Sioufi MC, Heroiu I, Wong S, Le GH, Dri CE, Zheng YJ, Teopiz KM, Rhee TG, Lo HKY, Guillen-Burgos HF, McIntyre RS.

Acta Neuropsychiatr. 2026 Feb 13;38:e24. doi: 10.1017/neu.2026.10060.

Intervention points for the role of physical activity in prevention and treatment of Alzheimer's disease

Brendborg N, Febbraio MA.

J Physiol. 2026 Mar;604(6):2411-2420. doi: 10.1113/JP286747. Epub 2025 Apr 16.

[Genetically informed treatment in psychiatry: new dynamics through APOE and antibody treatment of Alzheimer's disease]

Müller DJ, Freitag CM, Heilbronner U, Nöthen MM, Perneczky R, Rietschel M, Schulte EC, Deckert J; Referat Genetische, molekulare und zelluläre Neurowissenschaften der DGPPN.

Nervenarzt. 2026 Jan;97(1):82-85. doi: 10.1007/s00115-025-01839-1. Epub 2025 Jun 23.

Targeting the C5-C5aR1 axis: A promising therapeutic strategy for Alzheimer's disease and amyotrophic lateral sclerosis by unlocking neuroprotection

Ge TQ, Wang P, Guan PP.

Biochem Pharmacol. 2026 Jan;243(Pt 1):117518. doi: 10.1016/j.bcp.2025.117518. Epub 2025 Nov 2.

Next-generation neurotherapeutics: mechanistic insights on monoclonal antibodies in Alzheimer's disease

Sharma A, Singh TG.

Brain Res. 2026 Jan 1;1870:150047. doi: 10.1016/j.brainres.2025.150047. Epub 2025 Nov 13.

Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy

Sun T, Li Z, Xiao B, Yang J, Han M, Zhang J, Liu S, Ma J, Sang Z, Wang P.

Eur J Med Chem. 2026 Jan 15;302(Pt 3):118383. doi: 10.1016/j.ejmech.2025.118383. Epub 2025 Nov 17.

From genes to lifestyle: A multi-dimensional framework for Alzheimer's disease prevention and therapy

Su L, Wang Y.

Ageing Res Rev. 2026 Jan;113:102947. doi: 10.1016/j.arr.2025.102947. Epub 2025 Nov 19.

Transforming anti-Alzheimer's therapy by targeting endogenous receptorrial system through ligand-conjugated nanoformulations

Gawai M, Nistane N, Tatode AA, Qutub M, Umekar MJ, Premchandani T, Taksande JB.

Ageing Res Rev. 2026 Jan;114:102994. doi: 10.1016/j.arr.2025.102994. Epub 2025 Dec 13.

Targeting brain connectivity in Alzheimer's disease with repurposed drugs

Pini L, Imbimbo BP, Griffa A, Allali G, Pomara N.

Ageing Res Rev. 2026 Jan;114:103001. doi: 10.1016/j.arr.2025.103001. Epub 2025 Dec 18.

Protein and peptide based nanotherapeutics for the management of Alzheimer's disease: Current insights and future directions

Das SK, Bashir B, Kolekar KA, Harish V, Patle D, Vishwas S, Mittal N, Jha SK, Kumar P, Gupta G, Dureja H, Dua K, Chang D, Kuppusamy G, Singh SK.

Ageing Res Rev. 2026 Jan;114:103000. doi: 10.1016/j.arr.2025.103000. Epub 2025 Dec 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias